| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
46,306 |
44,210 |
$497K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
19,467 |
19,163 |
$263K |
| S9083 |
Global fee urgent care centers |
5,649 |
5,350 |
$252K |
| 94760 |
|
77,979 |
73,090 |
$168K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,172 |
6,858 |
$67K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
38,154 |
35,942 |
$62K |
| 99201 |
|
745 |
711 |
$43K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,646 |
4,438 |
$40K |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
21,313 |
20,409 |
$37K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,771 |
7,339 |
$31K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,563 |
9,155 |
$29K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
505 |
475 |
$27K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14,395 |
13,689 |
$25K |
| 71046 |
Radiologic examination, chest; 2 views |
5,961 |
5,845 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,786 |
5,390 |
$20K |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
13,374 |
12,717 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,376 |
16,092 |
$18K |
| 93000 |
|
3,213 |
3,187 |
$12K |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
24,665 |
23,561 |
$9K |
| 97597 |
|
1,187 |
1,088 |
$9K |
| 99406 |
|
5,495 |
5,324 |
$8K |
| 81002 |
|
9,452 |
9,210 |
$7K |
| 73630 |
|
1,307 |
1,286 |
$5K |
| G8484 |
Influenza immunization was not administered, reason not given |
26,203 |
24,691 |
$4K |
| 73130 |
|
809 |
793 |
$4K |
| 29540 |
|
658 |
656 |
$2K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
28,175 |
26,443 |
$2K |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
9,628 |
9,087 |
$2K |
| 73610 |
|
520 |
517 |
$2K |
| 99000 |
|
3,929 |
3,855 |
$2K |
| 29280 |
|
94 |
93 |
$2K |
| 69210 |
|
407 |
403 |
$1K |
| G8482 |
Influenza immunization administered or previously received |
2,340 |
2,253 |
$970.99 |
| 29260 |
|
176 |
175 |
$938.16 |
| 81025 |
|
1,577 |
1,556 |
$869.09 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
3,730 |
3,394 |
$855.16 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
411 |
381 |
$691.57 |
| 73562 |
|
147 |
139 |
$689.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,679 |
1,628 |
$667.02 |
| 73110 |
|
87 |
83 |
$583.30 |
| 1036F |
|
367 |
360 |
$444.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
966 |
932 |
$412.74 |
| G8710 |
Patient prescribed antibiotic |
3,458 |
3,362 |
$400.00 |
| 82962 |
|
1,416 |
1,399 |
$378.35 |
| G8711 |
Prescribed antibiotic on or within 3 days after the episode date |
6,887 |
6,770 |
$193.26 |
| 29530 |
|
12 |
12 |
$191.13 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
302 |
290 |
$181.85 |
| 36415 |
Collection of venous blood by venipuncture |
369 |
366 |
$173.08 |
| A6454 |
Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard |
791 |
785 |
$145.32 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
149 |
142 |
$143.44 |
| 72100 |
|
70 |
70 |
$137.84 |
| A6453 |
Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard |
1,039 |
1,032 |
$86.74 |
| G8708 |
Patient not prescribed antibiotic |
3,284 |
3,192 |
$70.00 |
| 73030 |
|
26 |
26 |
$51.72 |
| 71100 |
|
13 |
13 |
$51.33 |
| A7015 |
Aerosol mask, used with dme nebulizer |
287 |
276 |
$42.27 |
| 73140 |
|
12 |
12 |
$15.43 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
319 |
305 |
$1.90 |
| 86140 |
|
16 |
16 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$0.00 |
| 73564 |
|
15 |
14 |
$0.00 |
| G8712 |
Antibiotic not prescribed or dispensed |
712 |
710 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
258 |
246 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
719 |
701 |
$0.00 |
| 86318 |
|
14 |
14 |
$0.00 |
| 4004F |
|
77 |
69 |
$0.00 |
| 94060 |
|
27 |
27 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
16 |
15 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
29 |
29 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
34 |
34 |
$0.00 |
| 99401 |
|
20 |
20 |
$0.00 |